Preview

Вопросы современной педиатрии

Расширенный поиск

СТРАТЕГИИ КОНТРОЛЯ ВЕТРЯНОЙ ОСПЫ В РОССИИ. ИТОГИ МЕЖДУНАРОДНОГО СОВЕЩАНИЯ ЭКСПЕРТНОГО СОВЕТА ПО ВОПРОСАМ ПРОФИЛАКТИКИ ВЕТРЯНОЙ ОСПЫ (W.A.V.E.)

Аннотация

(Вопросы современной педиатрии. 2010;9(3):5-12)

Об авторах

А.А. Баранов
Научный центр здоровья детей РАМН, Москва
Россия


Н.И. Брико
Московская медицинская академия им. И.М. Сеченова
Россия


А.В. Горелов
Центральный НИИ эпидемиологии, Москва
Россия


М.П. Костинов
НИИ вакцин и сывороток им. И.И. Мечникова РАМН, Москва
Россия


О.П. Ковтун
Уральская государственная медицинская академия, Екатеринбург
Россия


Ю.В. Лобзин
НИИ детских инфекций, Санкт-Петербург
Россия


Список литературы

1. Guris D., Jumaan A.O., Mascola L. et al. Vaccines and preventable diseases: strategies for the control and investigation of varicella outbreaks. Доступно на: http://www.cdc.gov/vaccines/vpd-vac/varicella/outbreaks/manual.htm

2. CDC. Epidemiology and prevention of vaccine-preventable diseases. 2009. http://www.cdc.gov/vaccines/vpd-vac/varicella/outbreaks/manual.htm

3. Thomas H. Maugh II reports on Curns A.T. et al. Varicella mortality: trends before Vaccine Licensure in the United States, 1970–1994. J. Infect. Dis. 2008; 197: 120–126.

4. Nguyen H.Q., Jumaan A.O., Seward J.F. et al. Decline in mortality due to varicella after implementation of varicella vaccination in the United States. N. Engl. J. Med. 2005; 352(5): 450–458.

5. Seward J.F., Watson B.M., Peterson C.L. et al. Varicella disease after introduction of varicella vaccine in the United States, 1995-2000. JAMA. 2002; 287(5): 606–611.

6. Marin M., Güris D., Chaves S.S. et al. Prevention of varicella recommendations of the Advisory Committee on Immunization Practices (ACIP) Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, CDC. Varicella vaccine exposure during pregnancy.

7. Kwong J.C., Tanuseputro P., Zagorski B. et al. Impact of varicella vaccination on health care outcomes in Ontario, Canada: effect of a publicly funded program? Vaccine. 2008; 26: 6006–6012.

8. Passwell J.H., Hemo B., Levi Y. et al. Use of a computerized database to study the effectiveness of an attenuated varicella vaccine. Pediatr. Infect. Dis. J. 2004; 23: 221–226.

9. Valentim J., Sartori A.M.C., de Soárez P.C. et al. Cost-effectiveness analysis of universal childhood vaccination against varicella in Brazil. Vaccine. 2008; 26: 6281-6291.

10. Domingo J.D., Ridao M., Latour J. et al. A cost benefit analysis of routine varicella vaccination in Spain. Vaccine. 1999; 17: 1306–1311.

11. Watson B. Varicella-zoster vaccine in the USA: success for control of disease severity, but what next? Expert. Rev. Anti Infect. Ther. 2005; 3(1): 105–115.

12. Lieberman J.M., Williams W.R., Miller J.M. et al. Evalution of a quadrivalent MMRV vaccine in healthy children. Ped. Infect. Dis. J. 2006; 25 (7): 615–622.

13. Kuter B., Matthews H., Shinefield H. et al. Ten year follow-up of healthy children who received one or two injections of varicella vaccine. Pediatr. Infect. Dis. J. 2004; 23: 132–137.

14. Shinefield H., Black S., Digilio L. et al.http://www.ncbi.nlm.nih.gov/pubmed?term=%22Reisinger%20K%22%5BAuthor%5D Evalution of a quadrivalent measles,mumps, rubella and varicella vaccine in healthy childen. Pediatr. Infect. Dis. J. 2005; 24(8): 665–669.

15. Reisinger K.S., Brown M.L., Xu J. et al. A combination measles, mumps, rubella, and varicella vaccine (ProQuad) given to 4 to 6 year old healthy children vaccinated previously with M-M-RII and Varivax. Pediatrics. 2006; 117 (2): 265–272.

16. Ngai A.L., Staehle B.O., Kuter B.J. et al. Safety and immunogenicity of one vs. two injections of Oka/Merck varicella vaccine in healthy children. Pediatr. Infect. Dis. J. 1996; 15: 49–54.

17. Vázquez M., LaRussa P.S., Gershon A.A. et al. Effectiveness over time of varicella vaccine. JAMA. 2004; 291: 851-855.

18. CDC, Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 2007; 56 (No. RR-4).

19. Donati M., Zuckerman M., Dhawan A. et al. Response varicella immunization in pediatric liver transplant recipients. Transplantation. 2000; 70 (9): 1401–1404.

20. Giacchino R., Marcellini M., Timitilli A. et al. Varicella vaccine in children requiring renal or hepatic transplantation. Transplantation. 1995; 60: 1055–1056.

21. Laube G.F., Berger C., Goetschel P. et al. Immunization in children with chronic renal failure. Pediatr. Nephrol. 2002; 17: 638–642.

22. Geel A.L., Landman T.S., Kal J.A. Varicella zoster virus serostatus before and after kidney transplantation, and vaccination of adult kidney transplant candidates. Transplant Proc. 2006; 38 (10): 3418–3419.

23. Chavez T., Lopez M., de Sousa V. et al. Nonspecific immunoglobulin and granulocyte-macrophage colony-stimulating factor use in complicated varicella zoster: the first case report in a renal transplant recipient. Pediatr. Transplant. 2005; 9: 192–196.

24. Sauerbrei A., Prager J, Hengst U. et al. Varicella vaccination in children after bone marrow transplantation. Bone Marrow Transplant. 1997; 20 (5): 381–383.

25. Shinjoh M., Miyairi I., Hoshino K. et al. Effective and safe immunizations with live-attenuated vaccines for children after living donor liver transplantation. Vaccine. 2008; 26 (52): 6859–6863.

26. Gershon A., Steinberg S. NIAID Colaborative Varicella Vaccine Study Group. Live attenuated varicella vaccine: protection in healthy adults in comparison to leukemic children. Infect. Dis. 1990; 161: 661–666.

27. Gershon A., Steinberg S., Gelb L. et al. Varicella Collaborative Studi Group. A multicentre trial of live attenuated varicella vaccine in children with lrukemia in remission. Postgrad. Med. 1985; 61 (Suppl. 4): 73–78.

28. Hardy I., Gershon A.A., Steinberg S.P., LaRussa P., Varicella Vaccine Collaborative Study Group. The incidence of zoster after immunization with live attenuated varicella vaccine: a study in children with leukemia. N. Engl. J. Med. 1991; 325: 1545–1550.

29. Enders G., Miller E., Craddock-Watson J. et al. Consequences of varicella and herpes zoster in pregnancy, prospective study of 1739 cases. Lancet. 1994; 343: 1548–1551.

30. Petignat P., Vial Y., Laurini R., Hohlfeld P. et al. Fetal varicella-herpes zoster syndrome in early pregnancy: ultrasonographic and morphological correlation. Prenat. Diagn. 2001; 21 (2): 121–124.

31. Gentile D.A., Marco del Pont J., Lamy P. et al. Is varicella vaccine effective for post-exposure prophylaxis? 2nd World Congress of Paediatric Infectious Diseases, Manila, Philippines, 2−6 November 1999.

32. Mor M., Harel L., Kahan E. et al. Efficacy of postexposure immunization with live attenuated varicella vaccine in the household setting a pilot study. Vaccine. 2004; 23: 325–328.

33. Miron D., Lavi I., Kitov R. et al. Vaccine eff ectiveness and severity of varicella among previously vaccinated children during outbreaks in day-care centers with low vaccination coverage. Pediatr. Infect. Dis. J. 2005; 24 (3): 233–236.

34. Galil K., Lee B., Strine T. et al. Outbreak of varicella at a day-care center despite vaccination. N. Engl. J. Med. 2002; 347(24): 1909–1915.

35. Sheffer R, Segal, D, Rahamani et al. Effectiveness of the Oka/GSK attenuated varicella vaccine for the prevention of chickenpox in clinical practice in Israel. Pediatr. Infect. Dis J. 2005; 24 (5): 434–437.

36. Акимкин В.Г., Салмина Т.А., Волгин А.Р. и др. Опыт применения вакцины Варилрикс для экстренной специфической профилактики в очаге ветряной оспы. Эпидемиология и вакцинопрофилактика. 2010; 1: 67–71.

37. Parker A.A., Reynolds M.A., Leung J. et al. Challenges to implementing second-dose varicella vaccination during an outbreak in the absence of a routine 2-dose vaccination requirement – Maine, 2006. J. Infect. Dis. 2008; 197 (Suppl. 2): 101–107.


Для цитирования:


Баранов А., Брико Н., Горелов А., Костинов М., Ковтун О., Лобзин Ю. СТРАТЕГИИ КОНТРОЛЯ ВЕТРЯНОЙ ОСПЫ В РОССИИ. ИТОГИ МЕЖДУНАРОДНОГО СОВЕЩАНИЯ ЭКСПЕРТНОГО СОВЕТА ПО ВОПРОСАМ ПРОФИЛАКТИКИ ВЕТРЯНОЙ ОСПЫ (W.A.V.E.). Вопросы современной педиатрии. 2010;9(3):5-12.

For citation:


Baranov A., Briko N., Gorelov A., Kostinov M., Kovtun O., Lobzin Y. STRATEGIES OF CONTROL OF VARICELLA IN RUSSIA. RESUME OF INTERNATIONAL CONFERENCE OF EXPERT COUNCIL «WORKING AGAINST VARICELLA IN EUROPE» (W.A.V.E.). Current Pediatrics. 2010;9(3):5-12.

Просмотров: 152


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 1682-5527 (Print)
ISSN 1682-5535 (Online)